Main Article Content

Israr Ullah
Dr. Amir Hamza Khan
Fnu Vishal
Hafiz Muhammad Irfan
Dr. Syed Qasim Shah
Dr. Niaz Ali Khan
Dr. Mehmood Ahmed
Subhan Ullah


ANTIBIOTICS, DIABETES, treatment, optimizing


Introduction: Infectious diseases, in their various forms, continue to pose significant public health challenges worldwide. These conditions often require the use of antibiotics, which are instrumental in treating bacterial infections and mitigating the associated risks.Objectives: The basic aim of the study is to find the association of antibiotics prescriptions and outcomes in patients with infectious disease and uncontrolled diabetes mellitus.Material and methods: This retrospective cohort study was conducted in Hayatabad Medical Complex Peshawar during January 2023 to July 2023. Data was collected from 220 patients. Data on patient age, gender, ethnicity, and duration of diabetes were extracted from electronic health records (EHRs).Results: Data was collected from 220 patients from both genders. The mean age of the patients was 57.4 ± 9.2 years. The mean duration of diabetes was 8.7±3.1 years. The most prevalent infectious diseases observed were respiratory tract infections (34.5%), followed by urinary tract infections (28.2%) and skin and soft tissue infections (19.1%). In terms of disease severity, 53.6% of patients presented with moderate to severe infections.Patients receiving guideline-adherent antibiotic therapy were more likely to experience a favorable treatment response (OR = 2.14, p = 0.005) and fewer complications (OR = 0.38, p = 0.026).Conclusion: It is concluded that guideline-adherent antibiotic therapy is associated with improved treatment responses and reduced complications. These findings underscore the pivotal role of evidence-based antibiotic selection in optimizing outcomes for this vulnerable patient population.

Abstract 124 | pdf Downloads 28


1. Mikkelsen, Kristian H., et al. "Use of Antibiotics and Risk of Type 2 Diabetes: A Population-Based Case-Control Study." The Journal of Clinical Endocrinology and Metabolism, vol. 100, no. 10, 2015, pp. 3633-3640,
2. E., Carlos, et al. "Susceptibility for Some Infectious Diseases in Patients With Diabetes: The Key Role of Glycemia." Frontiers in Public Health, vol. 9, 2021, p. 559595,
3. Peleg AY, Weerarathna T, McCarthy JS, Davis TM. Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev. (2007) 23:3–13. doi: 10.1002/dmrr.682
4. Pal R, Bhadada SK. COVID-19 and diabetes mellitus: an unholy interaction of two pandemics. Diabetes MetabSyndr. (2020) 14:513–7. doi: 10.1016/j.dsx.2020.04.049
5. Vichaibun V, Khananurak K, Sophonnithiprasert T. Comparative analysis of plasma total antioxidant capacity in patients with hyperglycemia and hyperglycemia plus dyslipidemia. Diabetes MetabSyndr. (2019) 13:90–4. doi: 10.1016/j.dsx.2018.08.029
6. Alkundi A, Mahmoud I, Musa A, Naveed S, Alshawwaf M. Clinical characteristics and outcomes of COVID-19 hospitalized patients with diabetes in the United Kingdom: a retrospective single centre study. Diabetes Res Clin Pract. (2020) 165:108263. doi: 10.1016/j.diabres.2020.108263
7. Kudsk KA, Laulederkind A, Hanna MK. Most infectious complications in parenterally fed trauma patients are not due to elevated blood glucose levels. J Parenter Enteral Nutr. (2001) 25:174–9. doi: 10.1177/0148607101025004174
8. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med. (1999) 341:1906–12. doi: 10.1056/nejm199912163412507
9. Alba-Loureiro TC, Munhoz CD, Martins JO, Cerchiaro GA, Scavone C, Curi R, et al. Neutrophil function and metabolism in individuals with diabetes mellitus. Braz J Med Biol Res. (2007) 40:1037–44. doi: 10.1590/s0100-879x2006005000143
10. Cristea OM, Avramescu CS, Balasoiu M, Popescu FD, Popescu F, Amzoiu MO. Urinary tract infection with Klebsiella pneumoniae in Patients with Chronic Kidney Disease. Curr Health Sci J. (2017) 43:137–48. doi: 10.12865/chsj.43.02.06
11. Wang X, Ma A, Han X, Chan L, Liang H, Litifu A, et al. T cell profile was altered in pulmonary tuberculosis patients with type 2 diabetes. Med Sci Monit. (2018) 24:636–42. doi: 10.12659/msm.905651
12. Muller LM, Gorter KJ, Hak E, Goudzwaard WL, Schellevis FG, Hoepelman AI, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis. (2005) 41:281–8. doi: 10.1086/431587
13. Sanz-Corbalán I, Lázaro-Martínez JL, García-Morales E, Molines-Barroso R, Álvaro-Afonso F, García-Álvarez Y. Advantages of early diagnosis of diabetic neuropathy in the prevention of diabetic foot ulcers. Diabetes Res Clin Pract. (2018) 146:148–54. doi: 10.1016/j.diabres.2017.12.018
14. Chang BB, Darling RC III, Paty PS, Lloyd WE, Shah DM, Leather RP. Expeditious management of ischemic invasive foot infections. Cardiovasc Surg. (1996) 4:792–5.
15. Zylla D, Gilmore G, Eklund J, Richter S, Carlson A. Impact of diabetes and hyperglycemia on health care utilization, infection risk, and survival in patients with cancer receiving glucocorticoids with chemotherapy. J Diabetes Complications. (2019) 33:335–9. doi: 10.1016/j.jdiacomp.2018.12.012
16. Hine JL, de Lusignan S, Burleigh D, Pathirannehelage S, McGovern A, Gatenby P, et al. Association between glycaemic control and common infections in people with Type 2 diabetes: a cohort study. Diabet Med. (2017) 34:551–7. doi: 10.1111/dme.13205
17. Chang MW, Huang CY, Liu HT, Chen YC, Hsieh CH. Stress-induced and diabetic hyperglycemia associated with higher mortality among intensive care unit trauma patients: cross-sectional analysis of the propensity score-matched population. Int J Environ Res Public Health. (2018) 15:992. doi: 10.3390/ijerph15050992
18. Marik PE, Raghavan M. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med. (2004) 30:748–56. doi: 10.1007/s00134-004-2167-y

Most read articles by the same author(s)